건병증 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 5.3%의 성장률(CAGR)을 기록하며 163억 5,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 스포츠 및 피트니스 활동 참여자 증가, 노인 인구 증가, 조기 힘줄 손상 관리에 대한 인식 증가, 최소침습적 시술의 가용성 증가, 의료 인프라 확대, 근골격계 모니터링용 웨어러블 기기 채택 증가 등 여러 요인에 기인합니다. 이 기간 동안 예상되는 주요 동향으로는 재생 치료의 채택, 힘줄 수복용 생물학적 제제 개발, 최소침습 수술 기술의 발전, 재활 모니터링용 웨어러블 기기의 혁신, 통증 관리 제제의 개선, AI 기반 진단 도구의 통합 등이 있습니다.
스포츠 부상 발생률의 증가는 건병증 시장의 확대를 촉진할 것으로 예상됩니다. 스포츠 부상은 운동 활동이나 운동 중 발생하는 신체적 부상을 의미하며, 경미한 염좌나 염좌에서 심각한 골절이나 탈구에 이르기까지 다양합니다. 스포츠 부상의 증가는 훈련 강도의 증가와 어린 나이의 경쟁과 관련이 있으며, 완전히 성숙하기 전에 발육 중인 근육과 관절에 과도한 스트레스를 가하는 것과 관련이 있습니다. 이러한 부상은 힘줄에 반복적인 스트레스와 급격한 과부하를 주어 미세한 파열과 염증, 시간이 지남에 따라 퇴행성 변화를 일으켜 건병증을 유발할 수 있습니다. 예를 들어, 2023년 11월 영국의 보험 중개회사인 Howden Group Holdings Ltd.는 2022년 10월부터 2023년 1월까지 잉글랜드 프리미어리그에서 발목 부상의 심각성이 170% 증가했으며, 2022년 FIFA 월드컵 카타르 대회 이후에는 종아리/정강이 부상이 200%, 햄스트링 부상이 130% 증가했다고 보고했습니다. 이처럼 스포츠 부상 발생률의 증가가 건병증 시장의 성장에 기여하고 있습니다.
건병증 시장의 주요 기업들은 치유를 촉진하고, 힘줄 재생을 개선하며, 회복 시간을 단축하기 위해 생체 유도 임플란트와 같은 첨단 제품 개발에 주력하고 있습니다. 생체유도성 임플란트는 힘줄과 같은 조직의 성장을 촉진하여 신체의 자연 치유 과정을 자극하여 힘줄 수복의 임상 결과를 개선하는 혁신적인 의료기기입니다. 예를 들어, 2023년 7월 영국의 의료 기술 기업 Smith+Nephew는 인도에서 REGENETEN Bioinductive Implant를 출시했습니다. 이 콜라겐 기반 기구는 특히 힘줄판 수복에서 손상 부위의 새로운 조직 성장을 유도하여 생물학적 치유를 촉진하여 힘줄 수복에 일대 변화를 가져옵니다. 이 임플란트의 가장 큰 특징은 최소침습적 전달 방법으로, 정형외과 의사가 기존 수술 기법을 변경하지 않고도 힘줄을 생물학적으로 보강할 수 있어 건병증 환자에게 빠르고 안전하며 효과적인 치료 옵션을 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 건병증 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 건병증 시장 : 성장률 분석
- 세계의 건병증 시장 실적 : 규모와 성장, 2019-2024년
- 세계의 건병증 시장 예측 : 규모와 성장, 2024-2029, 2034년
- 세계의 건병증 전체 시장(TAM)
제6장 시장 세분화
- 세계의 건병증 시장 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 아킬레스건염
- 선회근건판건염
- 외측상과염(테니스엘보)
- 슬개건염
- 기타 유형
- 세계의 건병증 시장 : 치료 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 치료
- 약
- 외과적 치료
- 재생의료
- 세계의 건병증 시장 : 투여 경로별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 경구
- 국소
- 주사제
- 세계의 건병증 시장 : 최종사용자별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 병원
- 클리닉
- 외래 수술 센터
- 재활 센터
- 세계의 건병증 시장, 아킬레스건염 종류별 하위 세분화, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 삽입 아킬레스건병증
- 비삽입성 아킬레스건 건병증
- 세계의 건병증 시장, 선회근건판건염 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 상과 건병증
- 극상근 건병증
- 견갑골 하 건병증
- 소원근 건병증
- 세계의 건병증 시장, 소토가와상과염(테니스엘보) 분류(유형별), 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 건 너무 사용에 의한 손상
- 건변성 손상
- 세계의 건병증 시장, 슬개건염 종류별 하위 세분화, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 슬개골 근위 부 건병증
- 원위 슬개골 건병증
- 세계의 건병증 시장, 기타 유형 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 드켈반 건병증
- 비골 건병증
- 플렉서 건병증
- 신근 건병증
제7장 지역별·국가별 분석
- 세계의 건병증 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 세계의 건병증 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 건병증 시장 : 경쟁 구도
- 건병증 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
- Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- Bayer AG Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- Sanofi SA
- Bristol-Myers Squibb Company
- Novartis AG
- GSK plc
- Medtronic Plc
- 3M Company
- Stryker Corporation
- Teva Pharmaceutical Industries
- Zimmer Biomet
- Smith & Nephew plc
- Coloplast A/S
- Arthrex
- Bioventus
- Tynor Orthotics
- Almatica Pharma Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 건병증 시장 2029년 : 새로운 기회를 제공하는 국가
- 건병증 시장 2029년 : 새로운 기회를 제공하는 부문
- 건병증 시장 2029년 : 성장 전략
제36장 부록
ksm
Tendinopathy is a condition that affects the tendons, leading to pain, swelling, and reduced movement or strength. It is typically caused by repetitive stress or overuse, resulting in the deterioration of tendon tissue rather than acute inflammation.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main types of tendinopathy include Achilles tendinopathy, rotator cuff tendinopathy, lateral epicondylitis (tennis elbow), patellar tendinopathy, and others. Achilles tendinopathy specifically refers to an injury to the Achilles tendon, which connects the calf muscles to the heel bone. Treatment options for tendinopathy include therapy, medications, surgical interventions, and regenerative medicine approaches. The condition can be managed using various routes of administration, such as oral, topical, and injectable methods. These treatments are provided in various healthcare settings, including hospitals, clinics, and ambulatory surgical centers.
The tendinopathy market research report is one of a series of new reports from The Business Research Company that provides tendinopathy market statistics, including the tendinopathy industry global market size, regional shares, competitors with the tendinopathy market share, detailed tendinopathy market segments, market trends, and opportunities, and any further data you may need to thrive in the tendinopathy industry. This tendinopathy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The tendinopathy market size has grown strongly in recent years. It will grow from$12.63 billion in 2024 to $13.32 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth during the historic period can be attributed to several factors, including the rising incidence of sports-related injuries, a growing aging population, increased awareness of musculoskeletal disorders, the expanding availability of physical therapy services, and greater healthcare spending globally.
The tendinopathy market size is expected to see strong growth in the next few years. It will grow to$16.35 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth during the forecast period can be attributed to several factors, including increasing participation in sports and fitness activities, a rising geriatric population, growing awareness of early tendon injury management, the increasing availability of minimally invasive procedures, expanding healthcare infrastructure, and the rising adoption of wearable devices for musculoskeletal monitoring. Major trends expected during this period include the adoption of regenerative therapies, the development of biologics for tendon repair, advancements in minimally invasive surgical techniques, innovations in wearable devices for rehabilitation monitoring, improvements in pain management formulations, and the integration of AI-driven diagnostic tools.
The growing incidence of sports injuries is expected to drive the expansion of the tendinopathy market. Sports injuries refer to physical injuries sustained during athletic activities or exercise, ranging from minor sprains and strains to more severe fractures or dislocations. The rise in sports injuries is linked to increased training intensity and competition at younger ages, which places excessive stress on developing muscles and joints before they are fully matured. These injuries can lead to tendinopathy by subjecting tendons to repetitive stress or sudden overload, causing microscopic tears, inflammation, and degeneration over time. For example, in November 2023, Howden Group Holdings Ltd., a UK-based insurance intermediary company, reported that the severity of ankle injuries in the English Premier League increased by 170% between October 2022 and January 2023, while calf/shin injuries surged by 200% and hamstring injuries rose by 130%, following the FIFA World Cup Qatar 2022. As such, the rising incidence of sports injuries is contributing to the growth of the tendinopathy market.
Leading companies in the tendinopathy market are focusing on developing advanced products, such as bioinductive implants, to accelerate healing, improve tendon regeneration, and reduce recovery time. Bioinductive implants are innovative medical devices that stimulate the body's natural healing process by promoting the growth of tendon-like tissue, leading to improved clinical outcomes in tendon repair. For example, in July 2023, Smith+Nephew, a UK-based medical technology company, launched the REGENETEN Bioinductive Implant in India. This collagen-based device transforms tendon repair by encouraging biological healing through the induction of new tissue growth at the injury site, particularly for rotator cuff repairs. A key feature of the implant is its minimally invasive delivery method, which allows orthopedic surgeons to biologically reinforce the tendon without changing existing surgical techniques, offering a quicker, safer, and more effective treatment option for tendinopathy patients.
In April 2023, Vander-Bend Manufacturing, Inc., a U.S.-based medical technology company, acquired Omni Components Corporation for an undisclosed amount. With this acquisition, Vander-Bend aims to expand its precision manufacturing capabilities, enhance its product offerings in the medical technology sector, and strengthen its position in the market by integrating Omni Components Corporation's expertise in producing complex, high-precision components. Omni Components Corporation is a U.S.-based medical device company specializing in tendon surgeries.
Major players in the tendinopathy market are Pfizer Inc., Johnson and Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Novartis AG, GSK plc, Medtronic Plc, 3M Company, Stryker Corporation, Teva Pharmaceutical Industries, Zimmer Biomet, Smith & Nephew plc, Coloplast A/S, Arthrex, Bioventus, Tynor Orthotics, Almatica Pharma Inc.
North America was the largest region in the tendinopathy market in 2024. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the tendinopathy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The tendinopathy market consists of revenues earned by entities by providing services such as physical therapy and rehabilitation programs, pain management, arthroscopic debridement, and occupational therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The tendinopathy market also include sales of nonsteroidal anti-inflammatory drugs, creams and gels, and capsaicin creams. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Tendinopathy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on tendinopathy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for tendinopathy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tendinopathy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Achilles Tendinopathy; Rotator Cuff Tendinopathy; Lateral Epicondylitis (Tennis Elbow); Patellar Tendinopathy; Other Types
- 2) By Treatment Type: Therapy; Medication; Surgical Treatment; Regenerative Medicine
- 3) By Route Of Administration: Oral; Topical; Injectable
- 4) By End User: Hospitals; Clinics; Ambulatory Surgical Centers; Rehabilitation Centers
- Subsegments:
- 1) By Achilles Tendinopathy: Insertional Achilles Tendinopathy; Non-insertional Achilles Tendinopathy
- 2) By Rotator Cuff Tendinopathy: Supraspinatus Tendinopathy; Infraspinatus Tendinopathy; Subscapularis Tendinopathy; Teres Minor Tendinopathy
- 3) By Lateral Epicondylitis (Tennis Elbow): Tendon Overuse Injuries; Tendon Degeneration Injuries
- 4) By Patellar Tendinopathy: Proximal Patellar Tendinopathy; Distal Patellar Tendinopathy
- 5) By Other Types: De Quervain's Tenosynovitis; Peroneal Tendinopathy; Flexor Tendinopathy; Extensor Tendinopathy
- Companies Mentioned: Pfizer Inc.; Johnson and Johnson; Merck & Co. Inc.; AbbVie Inc.; Bayer AG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Tendinopathy Market Characteristics
3. Tendinopathy Market Trends And Strategies
4. Tendinopathy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Tendinopathy Growth Analysis And Strategic Analysis Framework
- 5.1. Global Tendinopathy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Tendinopathy Market Growth Rate Analysis
- 5.4. Global Tendinopathy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Tendinopathy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Tendinopathy Total Addressable Market (TAM)
6. Tendinopathy Market Segmentation
- 6.1. Global Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Achilles Tendinopathy
- Rotator Cuff Tendinopathy
- Lateral Epicondylitis (Tennis Elbow)
- Patellar Tendinopathy
- Other Types
- 6.2. Global Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Therapy
- Medication
- Surgical Treatment
- Regenerative Medicine
- 6.3. Global Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Topical
- Injectable
- 6.4. Global Tendinopathy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Rehabilitation Centers
- 6.5. Global Tendinopathy Market, Sub-Segmentation Of Achilles Tendinopathy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Insertional Achilles Tendinopathy
- Non-insertional Achilles Tendinopathy
- 6.6. Global Tendinopathy Market, Sub-Segmentation Of Rotator Cuff Tendinopathy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Supraspinatus Tendinopathy
- Infraspinatus Tendinopathy
- Subscapularis Tendinopathy
- Teres Minor Tendinopathy
- 6.7. Global Tendinopathy Market, Sub-Segmentation Of Lateral Epicondylitis (Tennis Elbow), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tendon Overuse Injuries
- Tendon Degeneration Injuries
- 6.8. Global Tendinopathy Market, Sub-Segmentation Of Patellar Tendinopathy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Proximal Patellar Tendinopathy
- Distal Patellar Tendinopathy
- 6.9. Global Tendinopathy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- De Quervain's Tenosynovitis
- Peroneal Tendinopathy
- Flexor Tendinopathy
- Extensor Tendinopathy
7. Tendinopathy Market Regional And Country Analysis
- 7.1. Global Tendinopathy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Tendinopathy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Tendinopathy Market
- 8.1. Asia-Pacific Tendinopathy Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Tendinopathy Market
- 9.1. China Tendinopathy Market Overview
- 9.2. China Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Tendinopathy Market
- 10.1. India Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Tendinopathy Market
- 11.1. Japan Tendinopathy Market Overview
- 11.2. Japan Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Tendinopathy Market
- 12.1. Australia Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Tendinopathy Market
- 13.1. Indonesia Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Tendinopathy Market
- 14.1. South Korea Tendinopathy Market Overview
- 14.2. South Korea Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Tendinopathy Market
- 15.1. Western Europe Tendinopathy Market Overview
- 15.2. Western Europe Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Tendinopathy Market
- 16.1. UK Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Tendinopathy Market
- 17.1. Germany Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Tendinopathy Market
- 18.1. France Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Tendinopathy Market
- 19.1. Italy Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Tendinopathy Market
- 20.1. Spain Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Tendinopathy Market
- 21.1. Eastern Europe Tendinopathy Market Overview
- 21.2. Eastern Europe Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Tendinopathy Market
- 22.1. Russia Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Tendinopathy Market
- 23.1. North America Tendinopathy Market Overview
- 23.2. North America Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Tendinopathy Market
- 24.1. USA Tendinopathy Market Overview
- 24.2. USA Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Tendinopathy Market
- 25.1. Canada Tendinopathy Market Overview
- 25.2. Canada Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Tendinopathy Market
- 26.1. South America Tendinopathy Market Overview
- 26.2. South America Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Tendinopathy Market
- 27.1. Brazil Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Tendinopathy Market
- 28.1. Middle East Tendinopathy Market Overview
- 28.2. Middle East Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Tendinopathy Market
- 29.1. Africa Tendinopathy Market Overview
- 29.2. Africa Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Tendinopathy Market Competitive Landscape And Company Profiles
- 30.1. Tendinopathy Market Competitive Landscape
- 30.2. Tendinopathy Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
31. Tendinopathy Market Other Major And Innovative Companies
- 31.1. Sanofi SA
- 31.2. Bristol-Myers Squibb Company
- 31.3. Novartis AG
- 31.4. GSK plc
- 31.5. Medtronic Plc
- 31.6. 3M Company
- 31.7. Stryker Corporation
- 31.8. Teva Pharmaceutical Industries
- 31.9. Zimmer Biomet
- 31.10. Smith & Nephew plc
- 31.11. Coloplast A/S
- 31.12. Arthrex
- 31.13. Bioventus
- 31.14. Tynor Orthotics
- 31.15. Almatica Pharma Inc.
32. Global Tendinopathy Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Tendinopathy Market
34. Recent Developments In The Tendinopathy Market
35. Tendinopathy Market High Potential Countries, Segments and Strategies
- 35.1 Tendinopathy Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Tendinopathy Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Tendinopathy Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
- 250617_r34990_Tendinopathy_GMR_2025
